FDB

MEDITECH to Spotlight Intelligent Interoperability at HIMSS24

Retrieved on: 
Thursday, March 7, 2024

As a longtime interoperability leader and advocate, MEDITECH is once again excited to feature its latest interoperability innovations in the HIMSS Interoperability Showcase.

Key Points: 
  • As a longtime interoperability leader and advocate, MEDITECH is once again excited to feature its latest interoperability innovations in the HIMSS Interoperability Showcase.
  • MEDITECH will present its interoperability strategy at the Interoperability Showcase Spotlight Theater on Wednesday, March 13 at 11:15 a.m. in the “Intelligent Interoperability” session.
  • “Intelligent interoperability opens the doors to innovation by leveraging the flexibility and scalability of the cloud , along with modern and open data standards like SMART apps and FHIR APIs.
  • MEDITECH will also share its Canadian interoperability strategy at the “Achieving a Collaborative Approach to Meaningful Interoperability Across Canada” session.

FDB Showcases How to Elevate the Clinician Experience at HIMSS24

Retrieved on: 
Thursday, March 7, 2024

SOUTH SAN FRANCISCO, Calif., March 7, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, will showcase how provider organizations can elevate the clinician experience at the 2024 HIMSS Global Health Conference & Exhibition in Orlando, March 11-15. Through patient-specific clinical decision support (CDS), simplified patient instructions that help lead to better medication adherence, and a more flexible ePrescribing network that enables the smooth flow of prescriptions between prescribers, payers, and pharmacies, FDB is helping solve major challenges for healthcare delivery organizations today.

Key Points: 
  • Attendees at a HIMSS24 education session and visitors to FDB booth #1747 in the HIMSS24 exhibit hall will discover how leading hospitals and health systems are using FDB PatientFirst™ solutions.
  • HIMSS24 attendees will learn how NCH (Naples Comprehensive Health) used FDB Targeted Medication Warnings with FDB AlertSpace® to elevate the experience of its physicians and to improve patient safety and Leapfrog CPOE test results.
  • These CDS Heroes are on a mission to ignite actionable guidance, transform clinician workflows, elevate patient safety and outcomes, and banish alert overload for a better clinician experience.
  • "Elevate Your Experience": Unwind with Wine, Beer & Gourmet Popcorn
    HIMSS24 attendees are invited to join FDB for a casual in-booth reception to network with industry experts and peers.

FDB and WebMD Ignite Collaborate to Drive Medication Safety and Adherence

Retrieved on: 
Tuesday, March 5, 2024

SOUTH SAN FRANCISCO, Calif. and NEW YORK, March 5, 2024 /PRNewswire/ -- FDB (First Databank), the leading provider of drug knowledge that helps healthcare professionals make more precise decisions, and WebMD Ignite, a full-service growth partner for organizations across the healthcare industry, today announced a collaboration to enhance patient discharge education to improve prescription drug safety and adherence. The collaboration also aims to increase patients' health literacy and engagement in care plans.

Key Points: 
  • WebMD Ignite will integrate content from Meducation®, FDB's cloud-based solution that delivers simplified and personalized medication instructions to all patients, into prescribers' electronic health record (EHR) systems and patient portals through WebMD Ignite's Krames On FHIR® platform.
  • Krames On FHIR is the leading patient education platform providing current educational content directly in the patient portal.
  • "Effective patient medication education is critical to improving patient outcomes," said Charles Lee, MD, senior director of clinical knowledge and senior advisor for health literacy and language barriers at FDB.
  • This integration of Meducation with WebMD Ignite's Krames On FHIR platform offers patients of all backgrounds simplified, easy-to-follow, actionable medication instructions, along with other valuable educational content from WebMD Ignite, to help protect their and their family's safety, increase care plan adherence and improve their outcomes."

NCH's Success Story at HIMSS24: Patient-Centric Alerts Boost Physician Experience, Patient Safety, and Leapfrog CPOE Test Results

Retrieved on: 
Friday, March 1, 2024

SOUTH SAN FRANCISCO, Calif., March 1, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announces the success of its collaboration with NCH (Naples Comprehensive Health) in Southwest Florida. NCH has leveraged FDB solutions to optimize medication decision support, making alerts more meaningful and relevant to clinicians while significantly reducing overall alert volume.

Key Points: 
  • NCH has leveraged FDB solutions to optimize medication decision support, making alerts more meaningful and relevant to clinicians while significantly reducing overall alert volume.
  • In transitioning to a new EHR system, NCH physicians experienced a shift in their workflow, encountering non-critical-level medication decision support alerts for the first time.
  • The medication CDS optimization initiative has also contributed to NCH's improvement in its Leapfrog CPOE test results.
  • This partnership underscores NCH's commitment to enhancing patient safety and mitigating physician frustration associated with irrelevant alerts.

Therap Services' Advanced Medication History Tool Enhances Efficient Medication Recording for Improved Individual Care by Support Professionals

Retrieved on: 
Tuesday, February 13, 2024

Designed to enhance health and medication data tracking for improved outcomes, the Medication History tool simplifies the recording, monitoring, and managing of medication schedules for caregivers, making the process easier and more efficient.

Key Points: 
  • Designed to enhance health and medication data tracking for improved outcomes, the Medication History tool simplifies the recording, monitoring, and managing of medication schedules for caregivers, making the process easier and more efficient.
  • The tool's 'Import from Excel' function has been optimized, allowing users with specific roles to efficiently enter multiple medications for an individual at once.
  • In addition, Therap's Medication History tool is a component of its Health Tracking modules, offering a flexible approach to recording and monitoring various health data and generating detailed reports.
  • The Medication History tool is effectively utilized in conjunction with Therap's Medication Administration Record (MAR) module, allowing for data entered into the Medication History form to automatically populate within the MAR module and other relevant Therap modules.

BorgWarner Signs International Strategic Relationship Agreement with FinDreams Battery for LFP Battery Packs

Retrieved on: 
Thursday, February 8, 2024

BorgWarner to be the preferred manufacturer of LFP battery packs for commercial vehicle markets (class 3 and above) in Europe, the Americas, and parts of Asia Pacific

Key Points: 
  • BorgWarner to be the preferred manufacturer of LFP battery packs for commercial vehicle markets (class 3 and above) in Europe, the Americas, and parts of Asia Pacific
    AUBURN HILLS, Mich., Feb. 8, 2024 /PRNewswire/ -- BorgWarner Inc. (NYSE: BWA) today announced a strategic relationship agreement with FinDreams Battery, a subsidiary of BYD Company Limited.
  • Under this agreement, BorgWarner will be the only non-OEM localized manufacturer, unaffiliated with FinDreams Battery, with rights to localize LFP battery packs for commercial vehicles utilizing FinDreams Battery blade cells in Europe, the Americas, and select regions of Asia Pacific.
  • In addition to receiving state-of-the-art blade cells for manufacturing LFP battery packs in the covered geographies, BorgWarner will receive a license from FinDreams Battery to use FinDreams Battery's intellectual property related to its battery pack design and manufacturing process.
  • "We believe FinDreams Battery is right for BorgWarner in this area, with its 20-plus years of experience and success in LFP batteries for the mobility sector across China and Europe.

NCPDP Foundation Awards $150,000 Grant to RxLive to Automate Tracking of Physician Adoption of Pharmacists' Clinical Recommendations

Retrieved on: 
Wednesday, December 20, 2023

SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive, a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions. RxLive will use NCPDP standards along with RxLive's expansive network across both acute and ambulatory care settings, including its platform integration with the Surescripts network and Health Gorilla Health Information Exchange, to pilot a process that can be used for bidirectional communication of patient-specific clinical information that will allow pharmacists to consult with patients, share their clinical recommendations with physicians, and track adoption of pharmacists' recommendations - to better coordinate care and improve patient health outcomes.

Key Points: 
  • SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive , a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions.
  • "The NCPDP Foundation grant to RxLive has the potential to document at scale the measurable value pharmacists bring to patients and the patient care team," explained J.W.
  • The goal of the project is to quantify and analyze clinical interactions between pharmacists and patients and how often providers take action as a result of the pharmacist's clinical recommendations.
  • RxLive will introduce a natural language processing (NLP) interface to ease adoption of the Sig Format.

FDB Vela™ Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance

Retrieved on: 
Wednesday, December 6, 2023

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Vela™ ePrescribing network, one of FDB's newest solutions, has earned HITRUST Risk-based, 2-year (r2) Certified status demonstrating the highest level of information protection assurance.

Key Points: 
  • HITRUST Risk-based, 2-year (r2) Certified status demonstrates that FDB Vela has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk.
  • This achievement places FDB in an elite group of organizations worldwide that have earned this certification.
  • To achieve the HITRUST Risk-based, 2-year Certification, FDB Vela surpassed requirements across various comprehensive cybersecurity and data protection domains.
  • Individually, each element exceeds most other programs and collectively they make HITRUST Certification the most comprehensive, transparent, consistent and highest quality assessment available."

FDB Recognized by AMIA for Decades-Long Partnership & Contributions to Healthcare Informatics

Retrieved on: 
Monday, November 13, 2023

SOUTH SAN FRANCISCO, Nov. 13, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that it has received the Silver Corporate Partner Award presented by the American Medical Informatics Association (AMIA), the leading professional association for informatics professionals in healthcare. AMIA formally recognized FDB for this award for its generous contributions to the association and to the field of informatics at the AMIA 2023 Annual Symposium in New Orleans today.

Key Points: 
  • AMIA formally recognized FDB for this award for its generous contributions to the association and to the field of informatics at the AMIA 2023 Annual Symposium in New Orleans today.
  • As the voice of the nation's top biomedical and health informatics professionals, AMIA and its members play a leading role in assessing the effect of health innovations on health policy and advancing the field of healthcare informatics.
  • AMIA actively supports five domains in healthcare informatics: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.
  • Organizations, such as FDB, that strategically partner with AMIA demonstrate that they are industry leaders with valuable content and expertise to share.

Global Biologics CDMO Market Skyrockets to Nearly $13.4 Billion in 2022, Set to Reach $27 Billion by 2028 Driven by Rising R&D Activities and Demand for Biologics - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 8, 2023

The global Biologics Contract Development and Manufacturing Organization (CDMO) market witnessed remarkable growth, reaching a value of nearly $13.4 billion in 2022.

Key Points: 
  • The global Biologics Contract Development and Manufacturing Organization (CDMO) market witnessed remarkable growth, reaching a value of nearly $13.4 billion in 2022.
  • Similarly, the Asia-Pacific Biologics CDMO market is anticipated to surge from $3.1 billion in 2023 to $5.9 billion by 2028, displaying an impressive CAGR of 13.7% during the same forecast period.
  • The report further categorizes the global market for Biologics CDMO by cell line type, including mammalian, microbial, and other modalities.
  • The mammalian segment is projected to grow from $8.7 billion in 2022 to $18.2 billion by 2028, boasting a CAGR of 12.9% over this period.